Steqeyma 45 mg

STEQEYMA 45 MG is a subcutaneous solution containing ustekinumab, used for managing moderate to severe plaque psoriasis. This biologic medication helps reduce inflammation and improve skin condition.

STEQEYMA 45 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults. It works by targeting specific proteins in the immune system to reduce inflammation and slow down skin cell turnover. This can help alleviate symptoms such as red, scaly patches and itching. The medication is administered via subcutaneous injection, making it a convenient option for long-term management of psoriasis.

Common effects of STEQEYMA 45 MG may include redness, itching, or swelling at the injection site. Some individuals might experience headaches, fatigue, or mild upper respiratory infections. These effects are generally mild and temporary. Serious side effects are rare but can include infections or allergic reactions. Always consult a healthcare provider if you experience severe or persistent symptoms.

STEQEYMA 45 MG should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration guidelines provided by your healthcare provider. Inform your healthcare provider about any existing medical conditions or allergies before starting treatment. Regular monitoring may be required to assess the medication's effectiveness and safety.

STEQEYMA 45 MG may interact with other medications, particularly those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol and certain foods may also interact with the medication, so it is advisable to discuss any dietary considerations with your healthcare provider.